Breast Cancer 2021: Research, Risks and Recovery

Actions and Detail Panel


Event Information

Share this event

Date and Time



Online Event

Event description
Join Breast Cancer Trials and Australia's top breast cancer experts for a virtual Q&A to discuss the latest in breast cancer research.

About this Event

Join Breast Cancer Trials (BCT) and some of the country’s top breast cancer experts for a virtual Q&A to discuss the latest breast cancer research, breast cancer risks, the prevention of breast cancer and the BRCA-P clinical trial, and the role of exercise for people with breast cancer.

The panel includes Associate Professor Prue Francis, Associate Professor Nicholas Wilcken, Professor Geoffrey Lindeman and Professor Erica James, who will present and then answer associated questions from the online audience.

Topics that will be discussed during the Q&A are:

• Breast Cancer Trials: Research Update – Associate Professor Prue Francis

• Breast Cancer Risks – Associate Professor Nicholas Wilcken

• Breast Cancer Prevention and the BRCA-P Clinical Trial – Professor Geoffrey Lindeman

• Breast Cancer and Exercise – Professor Erica James

This online session hopes to offer a useful resource for people, helping to answer their breast cancer questions.

To take part in the Q&A, please register above. You will then be sent a link to watch the live Q&A webinar.

To submit a question to the panelists, please enter it during the registration process.

Breast Cancer Trials has been conducting breast cancer clinical trials research for more than 40 years, in a unique collaboration between researchers, clinical trial participants and supporters. The results of this research has improved the treatment of breast cancer, led to changes in the way breast cancer is managed and has saved millions of lives through international research collaboration.

The research program brings together almost 800 researchers in 107 institutions throughout Australia and New Zealand. And more than 16,000 women have participated in BCT clinical trials.

To find out more about Breast Cancer Trials or ways that you can support our research, visit our website at


Associate Professor Prue Francis

Associate Professor Prue Francis is the Head of Medical Oncology in the Breast Service at the Peter MacCallum Cancer Centre and also a consultant Medical Oncologist at St Vincent’s Hospital Melbourne. She holds an academic appointment as an Associate Professor at The University of Melbourne. Associate Professor Francis graduated from The University of Melbourne and in New York at the Memorial Sloan Kettering Cancer Centre. She is Chair of the Breast Cancer Trials Scientific Advisory Committee, holds an appointment as Conjoint Associate Professor at The University of Newcastle in the School of Medicine and Public Health and is a member of the Scientific Committee of the International Breast Cancer Study Group (IBCSG).

Associate Professor Nicholas Wilcken

Associate Professor Wilcken is the Director of Medical Oncology at the Crown Princess Mary Cancer Centre Westmead, Senior Staff Specialist at Nepean Hospital and Associate Professor of Medicine at the University of Sydney. His clinical interests are mainly in breast cancer and his research interests include translational oncology, systematic reviews and breast cancer clinical trials. He is currently the Co-ordinating Editor of the Cochrane Collaboration’s Breast Cancer Group. He has been an invited expert panel member for previous St Gallen Early Breast Cancer Consensus Conferences in Switzerland and is a member of the Steering Committee of the Early Breast Cancer Trialists’ Collaborative Group, based in Oxford, UK. He is a Board Director at Breast Cancer Trials (BCT) and was the Chair of the BCT Scientific Advisory Committee from 2011 to 2017.

Professor Geoffrey Lindeman

Professor Geoffrey Lindeman, a clinician-scientist, is Joint Head of the Cancer Biology and Stem Cells Division at the Walter and Eliza Hall Institute (WEHI) and a medical oncologist at the Peter MacCallum Cancer Centre and The Royal Melbourne Hospital. He completed his medical training at the University of Sydney, followed by Medical Oncology training at Royal Prince Alfred Hospital and Westmead Hospital. He carried out Ph.D. studies at WEHI before pursuing postdoctoral training in the Livingston Laboratory at the Dana-Farber Cancer Institute, Harvard Medical School. In 1998, he was appointed to WEHI, where he and Professor Jane Visvader jointly established a Breast Cancer Laboratory. Professor Lindeman was also appointed as a sessional oncologist at The Royal Melbourne Hospital, where he helped establish The Royal Melbourne Hospital Tissue Bank and Familial Cancer Centre. Following the relocation of the Peter MacCallum Cancer Centre to Parkville, he served as inaugural Director of the Parkville Familial Cancer Centre. Professor Lindeman is a Fellow of the Australian Academy of Health and Medical Sciences and the Australian Academy of Science. He is a former Board Director at Breast Cancer Trials.

Professor Erica James

Professor Erica James is a behavioural epidemiologist in the School of Medicine and Public Health at the University of Newcastle. She holds an undergraduate degree in exercise science, postgraduate qualifications in health promotion, a Masters in Business, and a PhD in public health (behavioural epidemiology). From 1998-2006 she was Lecturer/Senior Lecturer in Public Health Research at La Trobe University, and received an Excellence in Research Award (1999) and an Excellence in Supervision Award (2004). From 2007-09 she was a Senior Research Academic at the Centre for Health Research and Psycho-oncology (CHeRP) and in 2010 was appointed Associate Professor in Public Health at the University of Newcastle. From 2013-17 she was the Higher Degree Research (HDR) convenor for the School of Medicine and Public Health. From 2016-20 she was Program Convener of the Master of Public Health, and she is currently MD Theme Lead (Health, Society and Environment). From 2018-20 Professor James was Associate Dean (Teaching and Learning) for the School of Medicine and Public Health at the University of Newcastle. Professor James leads a program of research in multiple health behaviour change in relation to cancer control and prevention. She is immediate past chair of the Special Interest Group in Cancer for the International Society of Behavioural Nutrition and Physical Activity (ISBNPA), and a Chief Investigator in two University-funded Priority Research Centres: PRC in Health Behaviour; PRC for Physical Activity & Nutrition. Professor James is Secretary of the Executive Committee of Council of Academic Public Health Institutions Australasia (CAPHIA) and was conference chair for the 2020 teaching and learning forum.

Share with friends

Date and Time


Online Event

Save This Event

Event Saved